You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 148 No. 1, January 2012 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Study
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

ONLINE FIRST
Comparable Effectiveness of Endovenous Laser Ablation and High Ligation With Stripping of the Great Saphenous Vein

Two-Year Results of a Randomized Clinical Trial (RELACS Study)

Knuth Rass, MD; Norbert Frings, MD; Paul Glowacki; Corinna Hamsch, MD; Stefan Gräber, MD; Thomas Vogt, MD; Wolfgang Tilgen, MD

Arch Dermatol. 2012;148(1):49-58. doi:10.1001/archdermatol.2011.272

Objective  To compare the clinical efficacy and safety of endovenous laser treatment (EVLT) with high ligation and stripping (HLS) as standard treatment for great saphenous vein (GSV) insufficiency.

Design  Two-center randomized controlled trial with 2-year follow-up.

Setting  Interventions were performed on ambulatory and hospitalized patients at 2 vein centers, a university dermatology department (EVLT-treated group), and a specialized vein clinic (HLS-treated group).

Patients  Random sample of 400 patients with GSV insufficiency.

Interventions  Patients were assigned (1:1) to EVLT or HLS of the GSV from September 2004 through March 2007; 185 and 161 patients (limbs), respectively, were treated per protocol.

Main Outcome Measures  Clinically recurrent varicose veins after surgery (REVAS classification, primary study objective), duplex-detected saphenofemoral recurrence, clinical venous severity scoring (Homburg Varicose Vein Severity Score), hemodynamics (venous refilling time), quality of life (Chronic Venous Insufficiency Questionnaire 2), adverse effects, and visual analog scale–based evaluations of patients' satisfaction.

Results  Clinically recurrent varicose veins after surgery were similarly observed in both groups: 16.2% (EVLT-treated group) vs 23.1% (HLS-treated group); P = .15. Duplex-detected saphenofemoral refluxes occurred significantly more frequently after EVLT (17.8% vs 1.3%; P < .001). Both treatments equally improved medical condition (Homburg Varicose Vein Severity Score) and disease-related quality of life. Endovenous laser treatment caused more adverse effects (phlebitic reaction, tightness, dyspigmentation) but revealed advantages concerning hemodynamics, recovery, and cosmetic outcome.

Conclusions  Both EVLT and HLS are comparably safe and effective procedures to treat GSV incompetence. The significantly higher rate and the course of duplex-detected saphenofemoral recurrences after EVLT remain a matter of further investigations.

Trial Registration  isrctn.org Identifier: ISRCTN18322872


Author Affiliations: Department of Dermatology, Venerology, and Allergology (Drs Rass, Hamsch, Vogt, and Tilgen) and Institute of Medical Biometry, Epidemiology, and Medical Informatics (Dr Gräber), Saarland University Hospital, Homburg, Germany; Capio Mosel-Eifel-Klinik, Clinic for Vein Disorders, Bad Bertrich, Germany (Dr Frings and Mr Glowacki); and Department of Dermatology, University of Heidelberg, Heidelberg, Germany (Dr Hamsch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The relevance of the natural history of varicose veins and refunded care
Pannier and Rabe
Phlebology 2012;27:23-26.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2012 American Medical Association. All Rights Reserved.